{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-243881","form_type":"8-K","ticker":"SLNO","cik":"0001484565","company_name":"SOLENO THERAPEUTICS INC","filed_at":"2023-09-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.055104+00:00","generated_at":"2026-06-10T08:09:57.726239+00:00","sec_items":["1.02","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Soleno terminates at-the-market offering agreement with Cantor Fitzgerald; $7.67M sold out of $8.88M authorized","bullets":["Terminated Controlled Equity Offering Sales Agreement with Cantor Fitzgerald effective September 26, 2023.","Under the ATM prospectus, $7.67M of common stock sold out of $8.88M authorized capacity.","No further sales of common stock will be made under the ATM program.","Cantor waived the termination notice period, making termination immediate."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-243881","json":"https://secwatch.observer/filing/0001193125-23-243881.json","markdown":"https://secwatch.observer/filing/0001193125-23-243881.md","text":"https://secwatch.observer/filing/0001193125-23-243881.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1484565/000119312523243881/0001193125-23-243881-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1484565/000119312523243881/d555949d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T08:09:57.726239+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3330cef673fa1594edf92f80990dfab76abb596d","claim":"SOLENO THERAPEUTICS INC terminated Sales Agreement with Cantor Fitzgerald & Co. (effective 2023-09-26).","evidence_excerpt":"On September 26, 2023, Soleno Therapeutics, Inc. (the “Company”), provided notice to Cantor Fitzgerald & Co. (“Cantor”) of its election to terminate the Controlled Equity Offering Sales Agreement between them dated July 16, 2021 (the “Sales Agreement”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1484565/000119312523243881/0001193125-23-243881-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Cantor Fitzgerald & Co."},{"label":"Effective","value":"2023-09-26"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}